Mitsubishi UFJ Asset Management
PCVX icon

Mitsubishi UFJ Asset Management’s Vaxcyte PCVX Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6K Hold
372
– – ﹤0.01% 1311
2026
Q1 		$21.6K Hold
372
– – ﹤0.01% 1229
2025
Q4 		$17.3K Hold
372
– – ﹤0.01% 1262
2025
Q3 		$13.4K Hold
372
– – ﹤0.01% 1289
2025
Q2 		$12.1K Sell
372
-75,100
-100% -$2.46M ﹤0.01% 1299
2025
Q1 		$2.85M Hold
75,472
– – ﹤0.01% 697
2024
Q4 		$6.4M Buy
75,472
+15,200
+25% +$1.51M 0.01% 626
2024
Q3 		$6.89M Buy
60,272
+31,000
+106% +$2.79M 0.01% 606
2024
Q2 		$2.21M Buy
29,272
+29,210
+47,113% +$1.99M ﹤0.01% 716
2024
Q1 		$4.24K Hold
62
– – ﹤0.01% 1386
2023
Q4 		$3.87K Hold
62
– – ﹤0.01% 1398
2023
Q3 		$3.16K Buy
+62
New +$3.06K ﹤0.01% 1448

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Mitsubishi UFJ Asset Management's PCVX Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management held its Vaxcyte (PCVX) position steady in Q2 2026 at 372 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1311.

Mitsubishi UFJ Asset Management first reported a position in PCVX in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.89M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 372 shares of Vaxcyte worth $21.6K as of Q2 2026.
  • Mitsubishi UFJ Asset Management left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1311 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Vaxcyte in Q3 2023 and has held it in 12 quarters since.
  • Mitsubishi UFJ Asset Management's Vaxcyte position peaked at $6.89M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.